PLEASANTON, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, an emerging pharmaceutical company focused on developing small-molecule therapeutics to treat neurological and infectious diseases, selected Veeva System’s VBioPharma™ KOL Edition – part of the Veeva CRM suite. Selection of Veeva’s SaaS solution marks an important step in Adamas’ early-stage product commercialization strategy. Veeva CRM is currently being rolled out to Adamas’ customer facing teams in sales and marketing and clinical management, and will scale with the company as it grows.
